Kenvue Inc. (NYSE:KVUE) Shares Sold by K.J. Harrison & Partners Inc

K.J. Harrison & Partners Inc lessened its stake in Kenvue Inc. (NYSE:KVUE) by 84.7% during the fourth quarter, HoldingsChannel.com reports. The firm owned 66,348 shares of the company’s stock after selling 366,160 shares during the period. K.J. Harrison & Partners Inc’s holdings in Kenvue were worth $1,428,000 as of its most recent SEC filing.

Other large investors have also modified their holdings of the company. Vanguard Group Inc. acquired a new stake in Kenvue during the third quarter valued at approximately $2,944,816,000. FMR LLC grew its position in shares of Kenvue by 572.1% during the 3rd quarter. FMR LLC now owns 89,182,980 shares of the company’s stock valued at $1,790,794,000 after buying an additional 75,913,107 shares during the last quarter. Wellington Management Group LLP raised its stake in Kenvue by 576.1% during the third quarter. Wellington Management Group LLP now owns 71,686,830 shares of the company’s stock worth $1,439,472,000 after acquiring an additional 61,084,123 shares during the period. Massachusetts Financial Services Co. MA boosted its stake in Kenvue by 227.7% in the third quarter. Massachusetts Financial Services Co. MA now owns 61,091,189 shares of the company’s stock valued at $1,226,711,000 after acquiring an additional 42,449,470 shares during the period. Finally, Morgan Stanley raised its position in shares of Kenvue by 4,057.4% during the 3rd quarter. Morgan Stanley now owns 31,162,614 shares of the company’s stock worth $625,745,000 after purchasing an additional 30,413,040 shares during the period. Institutional investors own 97.64% of the company’s stock.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on KVUE. The Goldman Sachs Group assumed coverage on Kenvue in a research note on Friday, March 1st. They set a “neutral” rating and a $20.00 target price for the company. William Blair initiated coverage on shares of Kenvue in a report on Wednesday, April 3rd. They issued a “market perform” rating on the stock. JPMorgan Chase & Co. reduced their target price on shares of Kenvue from $25.00 to $24.00 and set an “overweight” rating for the company in a report on Friday, February 9th. Sanford C. Bernstein started coverage on Kenvue in a research report on Thursday, April 11th. They set an “underperform” rating and a $18.00 price objective for the company. Finally, Royal Bank of Canada decreased their target price on Kenvue from $25.00 to $24.00 and set an “outperform” rating on the stock in a report on Friday, February 9th. One equities research analyst has rated the stock with a sell rating, eight have assigned a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat, Kenvue presently has an average rating of “Hold” and a consensus target price of $24.85.

Kenvue Trading Down 0.8 %

Kenvue stock traded down $0.16 during trading hours on Friday, hitting $18.86. The company had a trading volume of 15,454,689 shares, compared to its average volume of 13,458,618. Kenvue Inc. has a fifty-two week low of $17.82 and a fifty-two week high of $27.80. The company has a quick ratio of 0.78, a current ratio of 1.12 and a debt-to-equity ratio of 0.69. The firm’s fifty day moving average is $19.84 and its 200-day moving average is $20.13.

Kenvue (NYSE:KVUE) last posted its quarterly earnings results on Thursday, February 8th. The company reported $0.31 EPS for the quarter, beating the consensus estimate of $0.28 by $0.03. Kenvue had a net margin of 9.87% and a return on equity of 15.62%. The business had revenue of $3.67 billion for the quarter, compared to analysts’ expectations of $3.78 billion. The firm’s quarterly revenue was down 2.7% on a year-over-year basis. Research analysts anticipate that Kenvue Inc. will post 1.15 EPS for the current year.

Kenvue Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, May 22nd. Investors of record on Wednesday, May 8th will be paid a $0.20 dividend. The ex-dividend date is Tuesday, May 7th. This represents a $0.80 annualized dividend and a dividend yield of 4.24%.

Kenvue Company Profile

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.